Cavendish Impact Capital

Massive Bio, Inc. is a New York-based company that offers testing and treatment advisory services tailored to cancer patients and oncologists. Founded in 2014, the company employs an artificial intelligence-powered platform to connect patients with clinical trials and optimize cancer care. Through its Personalized Oncology Advisor, Massive Bio integrates cancer genomics and targeted therapies into clinical decision-making, providing both diagnostic and treatment options, including access to clinical trials. The company operates two main platforms: a business-to-consumer (B2C) platform that delivers on-demand products and services for patients and their oncologists, and a business-to-business (B2B) platform designed for hospitals and insurance companies. Additionally, Massive Bio addresses patient enrollment challenges in clinical trials by utilizing advanced technology and real-world data to streamline processes, ensuring patients receive effective treatment while minimizing financial burdens. The company serves a diverse clientele that includes patients, oncologists, hospitals, and payers.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Turner Imaging Systems, Inc., founded in 2016 and based in Orem, Utah, specializes in the development, manufacturing, and marketing of innovative x-ray imaging systems. The company's flagship product, the Smart-C Mini-C Arm, is a battery-powered, portable fluoroscopy and x-ray imaging device designed to enhance accessibility and usability in various medical settings. This hand-transportable system allows healthcare professionals to acquire x-ray images conveniently, thereby improving the efficiency of fluoroscopy procedures. Turner Imaging Systems aims to expand the reach of x-ray imaging technology, particularly in underserved areas and humanitarian efforts globally.

Turner Imaging Systems, Inc., founded in 2016 and based in Orem, Utah, specializes in the development, manufacturing, and marketing of innovative x-ray imaging systems. The company's flagship product, the Smart-C Mini-C Arm, is a battery-powered, portable fluoroscopy and x-ray imaging device designed to enhance accessibility and usability in various medical settings. This hand-transportable system allows healthcare professionals to acquire x-ray images conveniently, thereby improving the efficiency of fluoroscopy procedures. Turner Imaging Systems aims to expand the reach of x-ray imaging technology, particularly in underserved areas and humanitarian efforts globally.

Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.